Merck KGaA (FRA:MRK) received a €105.00 ($125.00) price objective from equities research analysts at Goldman Sachs Group, Inc. (The) in a report released on Wednesday. The firm currently has a “neutral” rating on the healthcare company’s stock.

A number of other analysts have also weighed in on MRK. Deutsche Bank AG set a €106.00 ($126.19) price target on shares of Merck KGaA and gave the stock a “neutral” rating in a research note on Friday, August 4th. Commerzbank Ag set a €109.00 ($129.76) price target on shares of Merck KGaA and gave the stock a “neutral” rating in a research note on Wednesday, August 9th. Berenberg Bank set a €109.00 ($129.76) price target on shares of Merck KGaA and gave the stock a “neutral” rating in a research note on Friday, August 18th. Morgan Stanley set a €103.00 ($122.62) price target on shares of Merck KGaA and gave the stock a “neutral” rating in a research note on Monday, May 22nd. Finally, DZ Bank AG reiterated a “neutral” rating on shares of Merck KGaA in a report on Thursday, August 17th. Fourteen investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Merck KGaA presently has an average rating of “Hold” and an average target price of €107.71 ($128.23).

Shares of Merck KGaA (MRK) traded up 0.022% on Wednesday, reaching €95.623. 1,786 shares of the company’s stock were exchanged. The company has a market capitalization of €41.57 billion and a P/E ratio of 24.928. The stock’s 50-day moving average price is €93.50 and its 200-day moving average price is €102.64. Merck KGaA has a 1-year low of €89.00 and a 1-year high of €115.00.

WARNING: “Merck KGaA (MRK) Given a €105.00 Price Target at Goldman Sachs Group, Inc. (The)” was reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/09/10/merck-kgaa-mrk-given-a-105-00-price-target-at-goldman-sachs-group-inc-the.html.

About Merck KGaA

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.